List of Studies ( Metabolite:4-Acetylphenyl sulfate)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003673 | AN006033 | Identification of plasma metabolites responding to oxycodone exposure in rats | Blood | Rat | Addiction | University of Colorado Anschutz Medical Campus | Other |
| ST003546 | AN005827 | Improved Soil Health and Pasture Phytochemical Richness Underlies Improved Beef Nutrient Density in Southern US Grass-Finished Beef Systems | Muscle | Cow | Utah State University | Other | |
| ST003277 | AN005367 | LC-MS/MS spatial analysis of mouse GI | Blood | Mouse | Brown University | Other | |
| ST003277 | AN005367 | LC-MS/MS spatial analysis of mouse GI | Cecum | Mouse | Brown University | Other | |
| ST003277 | AN005367 | LC-MS/MS spatial analysis of mouse GI | Colon | Mouse | Brown University | Other | |
| ST003277 | AN005367 | LC-MS/MS spatial analysis of mouse GI | DSI | Mouse | Brown University | Other | |
| ST003277 | AN005367 | LC-MS/MS spatial analysis of mouse GI | Liver | Mouse | Brown University | Other | |
| ST003277 | AN005367 | LC-MS/MS spatial analysis of mouse GI | MSI | Mouse | Brown University | Other | |
| ST003277 | AN005367 | LC-MS/MS spatial analysis of mouse GI | PSI | Mouse | Brown University | Other | |
| ST003277 | AN005367 | LC-MS/MS spatial analysis of mouse GI | Stomach | Mouse | Brown University | Other | |
| ST003131 | AN005137 | Untargeted Metabolomics on mouse caecal contents | Cecum | Mouse | University College Cork | Other | |
| ST003032 | AN004971 | Effects of Preanalytical Sample Collection and Handling on Comprehensive Metabolite Measurements in Human Urine Biospecimens | Urine | Human | National Center for Advancing Translational Sciences | Other | |
| ST002909 | AN004777 | Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis | Blood | Human | Melioidosis | University of Washington | Other |
| ST002837 | AN004639 | Bacterial tryptophan metabolites increased by prebiotic galactooligosaccharide reduce microglial reactivity and are associated with lower anxiety-like behavior (Blood) | Blood | Mouse | Anxiety | National Center for Advancing Translational Sciences | Other |
| ST002820 | AN004596 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) | Blood | Human | Tufts Medical Center | Other | |
| ST002819 | AN004592 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) | Blood | Human | Tufts Medical Center | Other | |
| ST002754 | AN004470 | Metabolomics analysis of maternal obesity model | Blood | Mouse | Fatty liver disease | University of Bonn | LC-MS |
| ST002498 | AN004656 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Blood | Human | Cancer | Weill Cornell Medicine | LC-MS |
| ST002149 | AN003519 | In vivo commensal control of Clostridioides difficile virulence | Cecum | Mouse | Brigham and Women's Hospital | LC-MS | |
| ST002090 | AN003414 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 2) | Feces | Mouse | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST002089 | AN003412 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Blood | Human | COPD | National Jewish Health | LC-MS |
| ST002088 | AN003408 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Blood | Human | COPD | National Jewish Health | LC-MS |
| ST002020 | AN003290 | TIPs Metabolomics (urine) | Urine | Human | Vanderbilt University Medical Center | LC-MS | |
| ST002019 | AN003289 | TIPs Metabolomics (blood) | Blood | Human | Vanderbilt University Medical Center | LC-MS | |
| ST002017 | AN003287 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) | Blood | Human | Vanderbilt University Medical Center | LC-MS | |
| ST001869 | AN003031 | WNK463 Inhibition on Right Ventricular metabolomics | Heart | Rat | Hypertension | University of Minnesota | LC-MS |
| ST001775 | AN002882 | Plasma metabolomics of diverse mouse strains infected with Plasmodium chabaudi | Blood | Mouse | Malaria | Stanford University | LC-MS |
| ST001749 | AN002850 | REACH Metabolomics Study | Blood | Human | Alzheimers disease | University of Wisconsin-Madison | LC-MS |
| ST001639 | AN002683 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Blood | Human | COPD | National Jewish Health | LC-MS |
| ST001517 | AN002519 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-III) | Blood | Human | Malaria | New York University Abu Dhabi | LC-MS |
| ST001516 | AN002516 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria (part-II) | Blood | Human | Malaria | New York University Abu Dhabi | LC-MS |
| ST001412 | AN002362 | Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST001411 | AN002361 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST001400 | AN002341 | Identification of distinct metabolic perturbations and associated immunomodulatory events during intra-erythrocytic development stage of pediatric Plasmodium falciparum malaria | Blood | Human | Malaria | New York University Abu Dhabi | LC-MS |
| ST001253 | AN002081 | Phenotyping Mouse blood metabolites in day and night in type 2 diabetes | Blood | Mouse | Diabetes | Indiana University School of Medicine | LC-MS |
| ST001158 | AN001916 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-II) | Feces | Mouse | Johns Hopkins University | LC-MS | |
| ST001157 | AN001915 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-I) | Blood | Mouse | Johns Hopkins University | LC-MS | |
| ST001144 | AN001887 | Microbial depletion and ozone exposure - serum (part II) | Blood | Mouse | Asthma | Harvard School of Public Health | GC-MS/LC-MS |
| ST000976 | AN001597 | GC6-74 matabolomic of TB (Part 3: Plasma_RPMI) | Blood | Human | Tuberculosis | Max Planck Institute for Infection Biology | LC-MS |
| ST000975 | AN001596 | GC6-74 metabolomics of TB vs healthy (Part 2: Serum) | Blood | Human | Tuberculosis | Max Planck Institute for Infection Biology | LC-MS |
| ST000974 | AN001595 | GC6-74 matabolomic of TB (Part 1: Plasma) | Blood | Human | Tuberculosis | Max Planck Institute for Infection Biology | LC-MS |
| ST000452 | AN000708 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Serum raw data | Blood | Mouse | University of North Carolina at Chapel Hill | GC-MS |
